Click for best price
Precision Cancer Therapies Market Size, Share 2022
Precision cancer therapies is an evolving approach to cancer care that aims to leverage new knowledge regarding the pathogenesis of cancer to more precisely target therapy.
This report contains market size and forecasts of Precision Cancer Therapies in Global, including the following market information:
Global Precision Cancer Therapies Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Precision Cancer Therapies market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hormone Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Precision Cancer Therapies include Abbott Laboratories, Bayer HealthCare, GlaxoSmithKline, OncoGenex Pharmaceuticals, Hospira, Boehringer Ingelheim, AstraZeneca and Aveo Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Precision Cancer Therapies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Precision Cancer Therapies Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Precision Cancer Therapies Market Segment Percentages, by Type, 2021 (%)
Hormone Therapy
Immunotherapies
Targeted Therapy
Monoclonal Antibody Therapy
Gene Therapy
Global Precision Cancer Therapies Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Precision Cancer Therapies Market Segment Percentages, by Application, 2021 (%)
Hospitals
Diagnostic Centers
Oncology Clinics
Research Institutes
Global Precision Cancer Therapies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Precision Cancer Therapies Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Precision Cancer Therapies revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Precision Cancer Therapies revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Bayer HealthCare
GlaxoSmithKline
OncoGenex Pharmaceuticals
Hospira
Boehringer Ingelheim
AstraZeneca
Aveo Pharmaceuticals
| Report Attributes |
Report Details |
| Report Title |
Precision Cancer Therapies Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
69 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Precision Cancer Therapies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Precision Cancer Therapies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Precision Cancer Therapies Overall Market Size
2.1 Global Precision Cancer Therapies Market Size: 2021 VS 2028
2.2 Global Precision Cancer Therapies Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Precision Cancer Therapies Players in Global Market
3.2 Top Global Precision Cancer Therapies Companies Ranked by Revenue
3.3 Global Precision Cancer Therapies Revenue by Companies
3.4 Top 3 and Top 5 Precision Cancer Therapies Companies in Global Market, by Revenue in 2021
3.5 Global Companies Precision Cancer Therapies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Precision Cancer Therapies Players in Global Market
3.6.1 List of Global Tier 1 Precision Cancer Therapies Companies
3.6.2 List of Global Tier 2 and Tier 3 Precision Cancer Therapies Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Precision Cancer Therapies Market Size Markets, 2021 & 2028
4.1.2 Hormone Therapy
4.1.3 Immunotherapies
4.1.4 Targeted Therapy
4.1.5 Monoclonal Antibody Therapy
4.1.6 Gene Therapy
4.2 By Type - Global Precision Cancer Therapies Revenue & Forecasts
4.2.1 By Type - Global Precision Cancer Therapies Revenue, 2017-2022
4.2.2 By Type - Global Precision Cancer Therapies Revenue, 2023-2028
4.2.3 By Type - Global Precision Cancer Therapies Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Precision Cancer Therapies Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Diagnostic Centers
5.1.4 Oncology Clinics
5.1.5 Research Institutes
5.2 By Application - Global Precision Cancer Therapies Revenue & Forecasts
5.2.1 By Application - Global Precision Cancer Therapies Revenue, 2017-2022
5.2.2 By Application - Global Precision Cancer Therapies Revenue, 2023-2028
5.2.3 By Application - Global Precision Cancer Therapies Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Precision Cancer Therapies Market Size, 2021 & 2028
6.2 By Region - Global Precision Cancer Therapies Revenue & Forecasts
6.2.1 By Region - Global Precision Cancer Therapies Revenue, 2017-2022
6.2.2 By Region - Global Precision Cancer Therapies Revenue, 2023-2028
6.2.3 By Region - Global Precision Cancer Therapies Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Precision Cancer Therapies Revenue, 2017-2028
6.3.2 US Precision Cancer Therapies Market Size, 2017-2028
6.3.3 Canada Precision Cancer Therapies Market Size, 2017-2028
6.3.4 Mexico Precision Cancer Therapies Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Precision Cancer Therapies Revenue, 2017-2028
6.4.2 Germany Precision Cancer Therapies Market Size, 2017-2028
6.4.3 France Precision Cancer Therapies Market Size, 2017-2028
6.4.4 U.K. Precision Cancer Therapies Market Size, 2017-2028
6.4.5 Italy Precision Cancer Therapies Market Size, 2017-2028
6.4.6 Russia Precision Cancer Therapies Market Size, 2017-2028
6.4.7 Nordic Countries Precision Cancer Therapies Market Size, 2017-2028
6.4.8 Benelux Precision Cancer Therapies Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Precision Cancer Therapies Revenue, 2017-2028
6.5.2 China Precision Cancer Therapies Market Size, 2017-2028
6.5.3 Japan Precision Cancer Therapies Market Size, 2017-2028
6.5.4 South Korea Precision Cancer Therapies Market Size, 2017-2028
6.5.5 Southeast Asia Precision Cancer Therapies Market Size, 2017-2028
6.5.6 India Precision Cancer Therapies Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Precision Cancer Therapies Revenue, 2017-2028
6.6.2 Brazil Precision Cancer Therapies Market Size, 2017-2028
6.6.3 Argentina Precision Cancer Therapies Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Precision Cancer Therapies Revenue, 2017-2028
6.7.2 Turkey Precision Cancer Therapies Market Size, 2017-2028
6.7.3 Israel Precision Cancer Therapies Market Size, 2017-2028
6.7.4 Saudi Arabia Precision Cancer Therapies Market Size, 2017-2028
6.7.5 UAE Precision Cancer Therapies Market Size, 2017-2028
7 Players Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Precision Cancer Therapies Major Product Offerings
7.1.4 Abbott Laboratories Precision Cancer Therapies Revenue in Global Market (2017-2022)
7.1.5 Abbott Laboratories Key News
7.2 Bayer HealthCare
7.2.1 Bayer HealthCare Corporate Summary
7.2.2 Bayer HealthCare Business Overview
7.2.3 Bayer HealthCare Precision Cancer Therapies Major Product Offerings
7.2.4 Bayer HealthCare Precision Cancer Therapies Revenue in Global Market (2017-2022)
7.2.5 Bayer HealthCare Key News
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Corporate Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Precision Cancer Therapies Major Product Offerings
7.3.4 GlaxoSmithKline Precision Cancer Therapies Revenue in Global Market (2017-2022)
7.3.5 GlaxoSmithKline Key News
7.4 OncoGenex Pharmaceuticals
7.4.1 OncoGenex Pharmaceuticals Corporate Summary
7.4.2 OncoGenex Pharmaceuticals Business Overview
7.4.3 OncoGenex Pharmaceuticals Precision Cancer Therapies Major Product Offerings
7.4.4 OncoGenex Pharmaceuticals Precision Cancer Therapies Revenue in Global Market (2017-2022)
7.4.5 OncoGenex Pharmaceuticals Key News
7.5 Hospira
7.5.1 Hospira Corporate Summary
7.5.2 Hospira Business Overview
7.5.3 Hospira Precision Cancer Therapies Major Product Offerings
7.5.4 Hospira Precision Cancer Therapies Revenue in Global Market (2017-2022)
7.5.5 Hospira Key News
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Corporate Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Precision Cancer Therapies Major Product Offerings
7.6.4 Boehringer Ingelheim Precision Cancer Therapies Revenue in Global Market (2017-2022)
7.6.5 Boehringer Ingelheim Key News
7.7 AstraZeneca
7.7.1 AstraZeneca Corporate Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Precision Cancer Therapies Major Product Offerings
7.7.4 AstraZeneca Precision Cancer Therapies Revenue in Global Market (2017-2022)
7.7.5 AstraZeneca Key News
7.8 Aveo Pharmaceuticals
7.8.1 Aveo Pharmaceuticals Corporate Summary
7.8.2 Aveo Pharmaceuticals Business Overview
7.8.3 Aveo Pharmaceuticals Precision Cancer Therapies Major Product Offerings
7.8.4 Aveo Pharmaceuticals Precision Cancer Therapies Revenue in Global Market (2017-2022)
7.8.5 Aveo Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Precision Cancer Therapies Market Opportunities & Trends in Global Market
Table 2. Precision Cancer Therapies Market Drivers in Global Market
Table 3. Precision Cancer Therapies Market Restraints in Global Market
Table 4. Key Players of Precision Cancer Therapies in Global Market
Table 5. Top Precision Cancer Therapies Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Precision Cancer Therapies Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Precision Cancer Therapies Revenue Share by Companies, 2017-2022
Table 8. Global Companies Precision Cancer Therapies Product Type
Table 9. List of Global Tier 1 Precision Cancer Therapies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Precision Cancer Therapies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Precision Cancer Therapies Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Precision Cancer Therapies Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Precision Cancer Therapies Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Precision Cancer Therapies Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Precision Cancer Therapies Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Precision Cancer Therapies Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Precision Cancer Therapies Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Precision Cancer Therapies Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Precision Cancer Therapies Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Precision Cancer Therapies Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Precision Cancer Therapies Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Precision Cancer Therapies Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Precision Cancer Therapies Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Precision Cancer Therapies Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Precision Cancer Therapies Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Precision Cancer Therapies Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Precision Cancer Therapies Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Precision Cancer Therapies Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Precision Cancer Therapies Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Precision Cancer Therapies Product Offerings
Table 32. Abbott Laboratories Precision Cancer Therapies Revenue (US$, Mn), (2017-2022)
Table 33. Bayer HealthCare Corporate Summary
Table 34. Bayer HealthCare Precision Cancer Therapies Product Offerings
Table 35. Bayer HealthCare Precision Cancer Therapies Revenue (US$, Mn), (2017-2022)
Table 36. GlaxoSmithKline Corporate Summary
Table 37. GlaxoSmithKline Precision Cancer Therapies Product Offerings
Table 38. GlaxoSmithKline Precision Cancer Therapies Revenue (US$, Mn), (2017-2022)
Table 39. OncoGenex Pharmaceuticals Corporate Summary
Table 40. OncoGenex Pharmaceuticals Precision Cancer Therapies Product Offerings
Table 41. OncoGenex Pharmaceuticals Precision Cancer Therapies Revenue (US$, Mn), (2017-2022)
Table 42. Hospira Corporate Summary
Table 43. Hospira Precision Cancer Therapies Product Offerings
Table 44. Hospira Precision Cancer Therapies Revenue (US$, Mn), (2017-2022)
Table 45. Boehringer Ingelheim Corporate Summary
Table 46. Boehringer Ingelheim Precision Cancer Therapies Product Offerings
Table 47. Boehringer Ingelheim Precision Cancer Therapies Revenue (US$, Mn), (2017-2022)
Table 48. AstraZeneca Corporate Summary
Table 49. AstraZeneca Precision Cancer Therapies Product Offerings
Table 50. AstraZeneca Precision Cancer Therapies Revenue (US$, Mn), (2017-2022)
Table 51. Aveo Pharmaceuticals Corporate Summary
Table 52. Aveo Pharmaceuticals Precision Cancer Therapies Product Offerings
Table 53. Aveo Pharmaceuticals Precision Cancer Therapies Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Precision Cancer Therapies Segment by Type in 2021
Figure 2. Precision Cancer Therapies Segment by Application in 2021
Figure 3. Global Precision Cancer Therapies Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Precision Cancer Therapies Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Precision Cancer Therapies Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Precision Cancer Therapies Revenue in 2021
Figure 8. By Type - Global Precision Cancer Therapies Revenue Market Share, 2017-2028
Figure 9. By Application - Global Precision Cancer Therapies Revenue Market Share, 2017-2028
Figure 10. By Region - Global Precision Cancer Therapies Revenue Market Share, 2017-2028
Figure 11. By Country - North America Precision Cancer Therapies Revenue Market Share, 2017-2028
Figure 12. US Precision Cancer Therapies Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Precision Cancer Therapies Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Precision Cancer Therapies Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Precision Cancer Therapies Revenue Market Share, 2017-2028
Figure 16. Germany Precision Cancer Therapies Revenue, (US$, Mn), 2017-2028
Figure 17. France Precision Cancer Therapies Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Precision Cancer Therapies Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Precision Cancer Therapies Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Precision Cancer Therapies Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Precision Cancer Therapies Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Precision Cancer Therapies Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Precision Cancer Therapies Revenue Market Share, 2017-2028
Figure 24. China Precision Cancer Therapies Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Precision Cancer Therapies Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Precision Cancer Therapies Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Precision Cancer Therapies Revenue, (US$, Mn), 2017-2028
Figure 28. India Precision Cancer Therapies Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Precision Cancer Therapies Revenue Market Share, 2017-2028
Figure 30. Brazil Precision Cancer Therapies Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Precision Cancer Therapies Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Precision Cancer Therapies Revenue Market Share, 2017-2028
Figure 33. Turkey Precision Cancer Therapies Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Precision Cancer Therapies Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Precision Cancer Therapies Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Precision Cancer Therapies Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Precision Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bayer HealthCare Precision Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GlaxoSmithKline Precision Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. OncoGenex Pharmaceuticals Precision Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Hospira Precision Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Boehringer Ingelheim Precision Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AstraZeneca Precision Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Aveo Pharmaceuticals Precision Cancer Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
